Skip header and navigation
Did you mean topic:"anaemia"? Also try anaemia.

Narrow By

22 records – page 1 of 2.

Anemia guidelines for family medicine

https://libcat.nshealth.ca/en/permalink/provcat23276
Anemia Review Panel. (2nd ed.) --Toronto, ON: MUMS Guideline Clearinghouse , 2008.
Call Number
WH 155 A578a 2008 REF
Location
Nova Scotia Hospital
Sub-Location
REFERENCE
Call Number
WH 155 A578a 2008 REF
Corporate Author
Anemia Review Panel
Edition
2nd ed.
Place of Publication
Toronto, ON
Publisher
MUMS Guideline Clearinghouse
Date of Publication
2008
Physical Description
78 p.
ISBN
9781894332088
Subjects (MeSH)
Anemia - diagnosis - Practice Guideline
Anemia - therapy - Practice Guideline
Format
Book
Location
Nova Scotia Hospital
Sub-Location
REFERENCE
Copies
2
Loan Period
2 weeks
Less detail

Anemia guidelines for family medicine

https://libcat.nshealth.ca/en/permalink/provcat26375
Anemia Review Panel. (3rd ed.) --Toronto, ON: MUMS Guideline Clearinghouse , 2014.
Call Number
WH 155 A578a 2014 REF
Location
Dickson Building
Sub-Location
REFERENCE
Call Number
WH 155 A578a 2014 REF
Corporate Author
Anemia Review Panel
Edition
3rd ed.
Place of Publication
Toronto, ON
Publisher
MUMS Guideline Clearinghouse
Date of Publication
2014
Physical Description
vii, 63 pages
Subjects (MeSH)
Anemia - diagnosis - Practice Guideline
Anemia - therapy - Practice Guideline
Family Practice - Handbooks
Format
Book
Location
Dickson Building
Sub-Location
REFERENCE
Copies
1
Loan Period
2 weeks
Less detail

Anemia in the elderly

https://libcat.nshealth.ca/en/permalink/provcat30443
--Boston, MA: Springer Science+Business Media , c2007.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Other Authors
Balducci, Lodovico
Ershler, William B
Bennett, John M
Place of Publication
Boston, MA
Publisher
Springer Science+Business Media
Date of Publication
c2007
ISBN
9780387495064
Subjects (MeSH)
Anemia - Aged
Subjects (LCSH)
Geriatrics
Hematology
Format
e-Book
Location
Online
Less detail

Anemia of chronic disease

https://libcat.nshealth.ca/en/permalink/provcat22222
Weiss, Günter. --Boca Raton, FL: Taylor and Francis , 2005.
Call Number
WH 155 A578 2005
Location
Dickson Building
Call Number
WH 155 A578 2005
Author
Weiss, Günter
Other Authors
Gordeuk, Victor R
Hershko, Chaim
Place of Publication
Boca Raton, FL
Publisher
Taylor and Francis
Date of Publication
2005
Physical Description
752 p.
Series Vol.
30
Series Title
Basic and clinical oncology
ISBN
0824759720
Subjects (MeSH)
Anemia
Erythropoiesis
Chronic Disease
Format
Book
Location
Dickson Building
Loan Period
3 weeks
Less detail

Clinical Aspects and Laboratory : Iron Metabolism, Anemias : concepts in the anemias of malignancies and renal and rheumatoid diseases

https://libcat.nshealth.ca/en/permalink/provcat30512
Wick, Manfred. (6th rev. and updated ed.) --Vienna, Austria: Springer , c2011.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Wick, Manfred
Other Authors
Pinggera, Wulf
Lehmann, Paul
Edition
6th rev. and updated ed.
Place of Publication
Vienna, Austria
Publisher
Springer
Date of Publication
c2011
Physical Description
1 online resource (196 p.)
ISBN
9783709100875
Subjects (MeSH)
Anemia
Anemia, Iron-Deficiency
Erythropoiesis - physiology
Iron Metabolism Disorders
Iron - metabolism
Subjects (LCSH)
Hematology
Format
e-Book
Location
Online
Less detail

Erythropoieis-stimulating agents (ESAs) for chronic kidney disease (CKD) : with active cancer or a history of cancer or stroke

https://libcat.nshealth.ca/en/permalink/chpams37446
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2217
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Hematinics - therapeutic use
Neoplasms
Stroke
Subjects (LCSH)
Chronic renal failure--Complications
Hematopoietic growth factors
Renal anemia--Chemotherapy
Cancer
Cerebrovascular disease
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully consider the risks and benefits of ESAs. The risks and benefits of ESAs are listed. Your health care team will talk with you about the risks and benefits of ESAs and other factors to consider when making the decision to take ESAs.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2217
Less detail

Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1493
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. How to take and store this medicine and possible side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Hematinics - therapeutic use
Subjects (LCSH)
Chronic renal failure--Complications
Hematopoietic growth factors
Renal anemia--Chemotherapy
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. How to take and store this medicine and possible side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1493
Less detail

Fer injectable et insuffisance rénale chronique (IRC)

https://libcat.nshealth.ca/en/permalink/chpams37473
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2161
Available Online
View Pamphlet
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygè…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Injectable iron and chronic kidney disease (CKD)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Si votre corps manque d’oxygène en raison d’une carence en fer, il se peut que vous soyez fatigué ou essoufflé. On appelle cela l’anémie ferriprive. Beaucoup de patients atteints d’insuffisance rénale chronique (IRC) ou dialysés souffrent d’anémie, car ils n’ont pas assez de globules rouges, et le corps a besoin de fer pour les fabriquer. Prendre du fer par injection permet donc au corps d’avoir suffisamment de fer pour fabriquer de l’hémoglobine, c’est-à-dire la protéine qui transporte l’oxygène. Ce dépliant explique comment prendre du fer injectable, ses effets possibles et comment le conserver.
This pamphlet is a French translation of the English pamphlet 1495, "Injectable Iron and Chronic Kidney Disease (CKD)". If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how to take injectable iron, side effects to watch for, and instructions on how to store the medication.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
2161
Less detail

Ferrous Sulfate/Iron

https://libcat.nshealth.ca/en/permalink/chpams37242
IWK. Pharmacy. Halifax, NS: IWK Health Centre , 2019.
Pamphlet Number
PL-1206
Available Online
View Pamphlet
Ferrous Sulfate/Iron provides the body with extra iron and helps to treat/prevent anemia (low red blood cells or low hemoglobin in the blood).
Available Online
View Pamphlet
Corporate Author
IWK. Pharmacy
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Anemia - drug therapy
Iron - therapeutic use
Subjects (LCSH)
Amemia--Treatment
Iron in human nutrition
Abstract
Ferrous Sulfate/Iron provides the body with extra iron and helps to treat/prevent anemia (low red blood cells or low hemoglobin in the blood).
Responsibility
IWK NICU Pharmacy Team, Halifax, NS
Pamphlet Number
PL-1206
Zone
All Zones
Less detail

Immune Hematology : Diagnosis and Management of Autoimmune Cytopenias

https://libcat.nshealth.ca/en/permalink/provcat42572
Jenny M. Despotovic, editor. --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
This text provides a concise yet comprehensive overview of the most common autoimmune cytopenias affecting adults and children. The book is divided into four sections, each of which focuses on a major autoimmune cytopenia. The first section features background, pathophysiology, presentation, evaluation, and treatment strategies for immune thrombocytopenia (ITP), the most common cause of antibody-mediated platelet destruction. The second section reviews common forms and treatment strategies for …
Available Online
View e-Book
Other Authors
Despotovic, Jenny M.
Responsibility
Jenny M. Despotovic, editor
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (x, 230 p.) : 13 illus., 11 illus. in color
ISBN
9783319732695
9783319732688 (print ed.)
9783319732701 (print ed.)
Subjects (MeSH)
Anemia, Hemolytic, Autoimmune - diagnosis
Anemia, Hemolytic, Autoimmune - therapy
Purpura, Thrombocytopenic, Idiopathic - diagnosis
Purpura, Thrombocytopenic, Idiopathic - therapy
Specialty
Hematology
Abstract
This text provides a concise yet comprehensive overview of the most common autoimmune cytopenias affecting adults and children. The book is divided into four sections, each of which focuses on a major autoimmune cytopenia. The first section features background, pathophysiology, presentation, evaluation, and treatment strategies for immune thrombocytopenia (ITP), the most common cause of antibody-mediated platelet destruction. The second section reviews common forms and treatment strategies for autoimmune hemolytic anemia (AIHA), including a chapter dedicated specifically to Evans Syndrome. The third section comprehensively reviews the pathophysiology, diagnosis and current management approaches to thrombotic thrombocytopenic purpura (TTP), a potentially life-threatening autoimmune syndrome. The book concludes with a final section on autoimmune neutropenia. Each section includes a review of common underlying systemic autoimmune conditions and immune deficiency syndromes that can accompany or cause autoimmune cytopenias. Written by experts in each content area, Immune Hematology: Diagnosis and Management of Autoimmune Cytopenias is a valuable resource for clinicians and professionals who treat patients afflicted with autoimmune cytopenias, including primary care providers, hematologist/oncologists, immunologists, among others.
Contents
Part I. Immune Thrombocytopenia (ITP) -- 1. Background of Immune Thrombocytopenia -- 2. Pathophysiology of Immune Thrombocytopenia -- 3. Presentation and Evaluation of Immune Thrombocytopenia -- 4. The Treatment of Immune Thrombocytopenia -- Part II. Autoimmune Hemolytic Anemia (AIHA) -- 5. Background, Presentation and Pathophysiology of Autoimmune Hemolytic Anemia -- 6. Treatment of Autoimmune Hemolytic Anemia -- 7. Evans Syndrome: Background, Clinical Presentation, Pathophysiology, and Management -- Part III. Thrombotic Thrombocytopenic Purpura (TTP) -- 8. Background and Presentation of Thrombotic Thrombocytopenic Purpura -- 9. Pathophysiology of Thrombotic Thrombocytopenic Purpura -- 10. Evaluation and Treatment of Thrombotic Thrombocytopenic Purpura -- Part IV. Autoimmune Neutropenia (AIN) -- 11. Background and Pathophysiology of Autoimmune Neutropenia -- 12. Evaluation and Management of Autoimmune Neutropenia.
Format
e-Book
Location
Online
Less detail

Injectable iron and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1495
Available Online
View Pamphlet
If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
If your body is not getting enough oxygen due to lack of iron, you may feel tired or short of breath. This is called iron deficiency anemia. Many patients with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. Getting iron injections can help make sure that you have enough iron in your body to make the oxygen-carrying part (hemoglobin) of your red blood cells. This pamphlet explains how to take injectable iron, side effects to watch for, and instructions on how to store the medication. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
1495
Less detail

IV (intravenous) iron therapy

https://libcat.nshealth.ca/en/permalink/chpams36485
Nova Scotia Health Authority. Perioperative Blood Management Service. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1332
Available Online
View Pamphlet
Iron is a mineral that the body needs to make red blood cells. When the body does not get enough iron, it can't make enough red blood cells to keep you healthy. This is called iron deficiency or iron deficiency anemia. This pamphlet outlines the symptoms, treatment, when this specific method is used, how therapy is given, and possible side effects. A list of health problems in which iron cannot be used as therapy is provided. Followup instructions and contact information is also given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Perioperative Blood Management Service
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Anemia, Iron-Deficiency - therapy
Subjects (LCSH)
Anemia
Abstract
Iron is a mineral that the body needs to make red blood cells. When the body does not get enough iron, it can't make enough red blood cells to keep you healthy. This is called iron deficiency or iron deficiency anemia. This pamphlet outlines the symptoms, treatment, when this specific method is used, how therapy is given, and possible side effects. A list of health problems in which iron cannot be used as therapy is provided. Followup instructions and contact information is also given.
Responsibility
Prepared by: Perioperative Blood Management Service; Department of Anesthesia, HI
Pamphlet Number
1332
Less detail

Low Red Blood Cells : Anemia

https://libcat.nshealth.ca/en/permalink/chpams37336
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
0002
Available Online
View Pamphlet
Low red blood cell count, called Anemia, can be caused by cancer or cancer treatment. This pamphlet lists the symptoms, treatments, coping mechanisms, and basic questions to ask your health care team.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Anemia
Antineoplastic Agents - adverse effects
Drug-Related Side Effects and Adverse Reactions
Hematologic Diseases
Radiotherapy - adverse effects
Self Care
Subjects (LCSH)
Anemia
Antineoplastic agents--Side effects
Blood cells--Diseases
Cancer--Chemotherapy--Complications
Radiotherapy--Complications
Self-care, Health
Specialty
Hematology
Abstract
Low red blood cell count, called Anemia, can be caused by cancer or cancer treatment. This pamphlet lists the symptoms, treatments, coping mechanisms, and basic questions to ask your health care team.
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
0002
Less detail

Management of anemia : a comprehensive guide for clinicians

https://libcat.nshealth.ca/en/permalink/provcat43233
edited by Robert Provenzano, Edgar V. Lerma, Lynda Szczech. --New York, NY: Springer , c2018.
Available Online
View e-Book
Location
Online
This concise and practical resource brings together recent advances in identifying and managing anemia of chronic disease (inflammation), genetically related anemia and anemia related to chronic end organ damage. Chapters provide a detailed analysis of the current science of anemia, approaches to different patient populations, comorbid conditions and nutritional aspects of anemia.
Available Online
View e-Book
Other Authors
Provenzano, Robert
Lerma, Edgar V.
Szczech, Lynda
Responsibility
edited by Robert Provenzano, Edgar V. Lerma, Lynda Szczech
Place of Publication
New York, NY
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xii, 243 p.) : 13 illus., 10 illus. in color
ISBN
9781493973606
9781493973583 (print ed.)
9781493973590 (print ed.)
Subjects (MeSH)
Anemia - etiology
Anemia - therapy
Specialty
Hematology
Abstract
This concise and practical resource brings together recent advances in identifying and managing anemia of chronic disease (inflammation), genetically related anemia and anemia related to chronic end organ damage. Chapters provide a detailed analysis of the current science of anemia, approaches to different patient populations, comorbid conditions and nutritional aspects of anemia.
Contents
Ch. 1: Disease state: Kidney Disease -- Ch. 2: Iron Deficiency Anemia -- Ch. 3: Nutritional anemia in adults and in elderly patients -- Ch. 4: Anemia of Chronic Disease -- Ch. 5: Current and Novel Drugs for Management of Anemia -- Ch. 6: Anemia of Chronic Kidney Disease -- Ch. 7: Anemia in Liver Disease -- Ch. 8: Anemia in the Patient with Chronic Lung Disease -- Ch. 9: Anemia in Malignancy -- Ch. 10: The Complex Relationships Between Iron Regulation, Obesity and Anemia -- Ch. 11: Post-Transplant Anemia -- Ch. 12: Anemia in children -- Ch. 13: Management of Sickle Cell Anemia.
Format
e-Book
Location
Online
Less detail

Medical and Surgical Complications of Sickle Cell Anemia

https://libcat.nshealth.ca/en/permalink/provcat39964
Ahmed Al-Salem. (1st ed.) --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book is a wide-ranging guide to the diagnosis and management of the numerous medical and surgical complications that may arise in patients with sickle cell anemia. After introductory chapters on the genetics, pathophysiology, clinical features, and variants of sickle cell anemia, the complications observed in different parts of the body are addressed in a series of well-illustrated chapters. The coverage includes splenic, hepatobiliary, musculoskeletal, gastrointestinal, ophthalmological, …
Available Online
View e-Book
Author
Al-Salem, Ahmed
Responsibility
Ahmed Al-Salem
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xiii, 349 p. : 305 illus., 99 illus. in color)
ISBN
9783319247625
9783319247601 (print ed.)
Subjects (MeSH)
Anemia, Sickle Cell - complications
Anemia, Sickle Cell - therapy
Abstract
This book is a wide-ranging guide to the diagnosis and management of the numerous medical and surgical complications that may arise in patients with sickle cell anemia. After introductory chapters on the genetics, pathophysiology, clinical features, and variants of sickle cell anemia, the complications observed in different parts of the body are addressed in a series of well-illustrated chapters. The coverage includes splenic, hepatobiliary, musculoskeletal, gastrointestinal, ophthalmological, cardio- and cerebrovascular, and renal complications, as well as acute chest syndrome, leg ulcers, hand and foot syndrome, acute appendicitis, and priapism. Treatment-oriented chapters consider perioperative management, blood transfusion therapy, hydroxyurea treatment, hematopoietic stem cell transplantation, and emerging strategies. The book is clearly written in a distinctive bullet point format for ease of reference and emphasizes especially aspects of practical significance. It will be of value for hematologists, general surgeons, internists, pediatricians, pediatric surgeons, fellows, residents, medical students, and nurses.
Contents
History of sickle cell anemia -- Genetics and pathophysiology of sickle cell anemia -- Variants of sickle cell anemia -- Clinical features of sickle cell anemia -- The spleen and sickle cell anemia -- Hepatobiliary complications of sickle cell anemia -- Acute chest syndrome and sickle cell anemia -- Musculoskeletal manifestations of sickle cell anemia -- Gastrointestinal complications of sickle cell anemia -- Leg ulcers in patients with sickle cell anemia -- The hand and foot syndrome in sickle cell anemia -- Acute appendicitis and sickle cell anemia -- Ophthalmological manifestations of sickle cell anemia -- Cardiovascular complications of sickle cell anemia -- Cerebrovascular complications of sickle cell anemia -- Renal complications of sickle cell anemia -- Priapism and sickle cell anemia -- Perioperative management of patients with sickle cell anemia -- Recent advances in the management of patients with sickle cell anemia -- Blood transfusion therapy for patients with sickle cell anemia -- Hydroxyurea treatment for sickle cell anemia -- Hematopoietic stem-cell transplantation for patients with sickle cell anemia.
Format
e-Book
Location
Online
Less detail

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1469
Available Online
View Pamphlet
Your red blood cells need iron to help carry oxygen through your body. Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Oral irons, such as ferrous sulfate, ferrous gluconate, ferrous fumarate, and FeraMAX® 150, will give you enough iron to make make hemoglobin. This will make sure your body gets enough oxygen. How to take and store these medicines, and what side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Abstract
Your red blood cells need iron to help carry oxygen through your body. Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Oral irons, such as ferrous sulfate, ferrous gluconate, ferrous fumarate, and FeraMAX® 150, will give you enough iron to make make hemoglobin. This will make sure your body gets enough oxygen. How to take and store these medicines, and what side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Pocket reference to renal anemia

https://libcat.nshealth.ca/en/permalink/provcat33539
Iain C Macdougall. (Second edition) --London, UK: Springer Healthcare , c2013.
Available Online
View e-Book
Location
Online
Pocket Reference to Renal Anemia, Second edition, provides a comprehensive overview of anemia in patients with renal disease, including the definition and causes of renal anemia, current management approaches, and the latest clinical practice guidelines. Key learning points are highlighted throughout the book and also listed at the end of the book for a quick reference. The book is useful for general physicians, fellows, and other healthcare professionals wishing to learn more about renal anemi…
Available Online
View e-Book
Author
Macdougall, Iain C
Responsibility
Iain C Macdougall
Edition
Second edition
Place of Publication
London, UK
Publisher
Springer Healthcare
Date of Publication
c2013
Physical Description
1 online resource (ix, 62 pages)
ISBN
9781907673481 (electronic bk.)
9781908517746
Subjects (MeSH)
Anemia
Erythropoietin - therapeutic use
Hematinics - therapeutic use
Iron - deficiency
Kidney Diseases - therapy
Subjects (LCSH)
Kidney Diseases - therapy
Anemia - therapy
Nephrology - methods
Hematology - methods
Renal anemia
Nephrology
Hematology
Abstract
Pocket Reference to Renal Anemia, Second edition, provides a comprehensive overview of anemia in patients with renal disease, including the definition and causes of renal anemia, current management approaches, and the latest clinical practice guidelines. Key learning points are highlighted throughout the book and also listed at the end of the book for a quick reference. The book is useful for general physicians, fellows, and other healthcare professionals wishing to learn more about renal anemia.
Contents
What is renal anemia? -- What is the cause of renal anemia? -- Stepwise approach to anemia management in patients with chronic kidney disease -- Excluding other causes of anemia -- Iron management -- Erythropoiesis-stimulating agent therapy -- Blood transfusions -- Guidelines on the management of renal anemia -- What is the future of renal anemia management? -- Conclusions.
Format
e-Book
Location
Online
Less detail

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology : Scientific and Clinical Aspects of Anemia in Cancer

https://libcat.nshealth.ca/en/permalink/provcat30127
edited by Mohammad Resa Nowrousian. (2nd rev. and enlarged ed.) --Vienna: Springer-Verlag , c2008.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Nowrousian, Mohammad Resa
Responsibility
edited by Mohammad Resa Nowrousian
Edition
2nd rev. and enlarged ed.
Place of Publication
Vienna
Publisher
Springer-Verlag
Date of Publication
c2008
ISBN
9783211694596
Subjects (MeSH)
Anemia - physiopathology
Anemia - therapy
Erythropoietin - therapeutic use
Neoplasms - complications
Subjects (LCSH)
Hematology
Oncology
Format
e-Book
Location
Online
Less detail

Sickle Cell Anemia : From Basic Science to Clinical Practice

https://libcat.nshealth.ca/en/permalink/provcat39739
Fernando Ferreira Costa, Nicola Conran, editors. --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
Although sickle cell anemia was the first molecular disease to be identified, its complex and fascinating pathophysiology is still not fully understood. A single mutation in the beta-globin gene incurs numerous molecular and cellular mechanisms that contribute to the plethora of symptoms associated with the disease. Our knowledge regarding sickle cell disease mechanisms, while still not complete, has broadened considerably over the last decades. Sickle Cell Anemia: From Basic Science to Clinica…
Available Online
View e-Book
Other Authors
Costa, Fernando Ferreira
Conran, Nicola
Responsibility
Fernando Ferreira Costa, Nicola Conran, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xv, 435 p. : 64 illus., 50 illus. in color)
ISBN
9783319067131
9783319067124 (print ed.)
Subjects (MeSH)
Anemia, Sickle Cell - physiopathology
Anemia, Sickle Cell - therapy
Abstract
Although sickle cell anemia was the first molecular disease to be identified, its complex and fascinating pathophysiology is still not fully understood. A single mutation in the beta-globin gene incurs numerous molecular and cellular mechanisms that contribute to the plethora of symptoms associated with the disease. Our knowledge regarding sickle cell disease mechanisms, while still not complete, has broadened considerably over the last decades. Sickle Cell Anemia: From Basic Science to Clinical Practice aims to provide an update on our current understanding of the disease's pathophysiology and use this information as a basis to discuss its manifestations in childhood and adulthood. Current therapies and prospects for the development of new approaches for the management of the disease are also covered.
Contents
1 Hemoglobin: Structure, Synthesis and Oxygen Transport -- 2 Sickle cell Anemia: History and Epidemiology -- 3 Overview of Sickle Cell Anemia Pathophysiology -- 4 Red Blood Cells and the Vaso-occlusive Process -- 5 Leukocytes in the vaso-occlusive process -- 6 Hypercoagulability and Sickle Cell Disease -- 7 Cardiovascular Adaptations to Anemia and the Role of Vascular Endothelium in Sickle Cell Disease Pathophysiology -- 8 Inflammation and Sickle Cell Anemia -- 9 Clinical Manifestations of Sickle Cell Anemia: Infants and Children -- 10 Treatment of Childhood Sickle Cell Disease -- 11 Priapism in Sickle Cell Disease: New aspects of pathophysiology -- 12 Clinical Manifestations and Treatment of Adult Sickle Cell -- 13 Hemoglobin Sß Thalassemia, SC Disease and SD Disease: Clinical and Laboratorial Aspects -- 14 Sickle Cell Disease in Africa and the Arabian Peninsula: Current Management and Challenges -- 15 Genetic Factors modifying sickle cell disease severity -- 16 Future Perspectives for the Treatment of Sickle Cell.
Format
e-Book
Location
Online
Less detail

Sickle Cell Disease and Hematopoietic Stem Cell Transplantation

https://libcat.nshealth.ca/en/permalink/provcat43145
Emily Riehm Meier, Allistair Abraham, Ross M. Fasano, editors. --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
This book provides a comprehensive, state-of-the art review of hematopoietic stem cell transplantation (HSCT) for sickle cell disease (SCD). The book reviews new data about risk prediction for severe SCD, outlines the unique challenges of HSCT for patients with SCD, profiles the supportive care guidelines for patients who are undergoing HSCT, highlights our current understanding of the best transfusion support for SCD patients prior to, during and after HSCT, and provides new perspectives about…
Available Online
View e-Book
Other Authors
Meier, Emily Riehm
Abraham, Allistair
Fasano, Ross M.
Responsibility
Emily Riehm Meier, Allistair Abraham, Ross M. Fasano, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xiii, 334 p.) : 21 illus., 16 illus. in color
ISBN
9783319623283
9783319623276 (print ed.)
9783319623290 (print ed.)
9783319872926 (print ed.)
Subjects (MeSH)
Anemia, Sickle Cell - therapy
Hematopoietic Stem Cell Transplantation
Specialty
Hematology
Regenerative Medicine
Abstract
This book provides a comprehensive, state-of-the art review of hematopoietic stem cell transplantation (HSCT) for sickle cell disease (SCD). The book reviews new data about risk prediction for severe SCD, outlines the unique challenges of HSCT for patients with SCD, profiles the supportive care guidelines for patients who are undergoing HSCT, highlights our current understanding of the best transfusion support for SCD patients prior to, during and after HSCT, and provides new perspectives about the ethics of HSCT for pediatric patients with SCD. Published in the last few years, several landmark phase III trials that utilize matched unrelated and haploidentical donors for HSCT in SCD patients are also placed in context with respect to current management. Written by experts in the field, Sickle Cell Disease and Hematopoietic Stem Cell Transplantation is a valuable resource for physicians and researchers dealing with and interested in this challenging, yet exciting, curative therapy for sickle cell disease, that will help guide patient management and stimulate investigative efforts.
Contents
Part I. Sickle Cell Disease -- Clinical Manifestations of Sickle Cell Disease Across the Lifespan -- Pathobiology of Sickle Cell Disease Vaso-Occlusion and Targeted Therapies -- Current Non-HSCT Related Treatments for SCD -- Risk Based Therapies for Sickle Cell Disease -- Transfusion Support of the Patient with Sickle Cell Disease Undergoing Transplantation -- Neurological Manifestations of Sickle Cell Disease and Their Impact on Allogeneic Hematopoietic Stem Cell Transplantation -- Part II. Hematopoietic Stem Cell Transplantation -- Overview of Hematopoietic Stem Cell Transplantation for Non-Malignant Diseases -- Unique Challenges of Hematopoietic Stem Cell Transplant for Sickle Cell Disease -- The Ethics of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease -- Psychosocial Care and Education of Children with Sickle Cell Disease Undergoing Hematopoietic Stem Cell Transplant and their Families -- Long Term Effects of Hematopoietic Stem Cell Transplantation for Sickle Cell Disease -- Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease -- Unrelated Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease -- Haploidentical Hematopoietic Cell Transplantation for Sickle Cell Disease -- Gene Therapy: The Path Toward Becoming a Realistic Cure for Sickle Cell Disease.
Format
e-Book
Location
Online
Less detail

22 records – page 1 of 2.